In this issue:
Opioid maintenance therapy reduces HCV incidence
Preventing HBV reactivation in HBsAg+ patients on R-CHOP
Viral BCP mutant linked to liver cirrhosis in HBV
New HCV intergenotypic recombinant GT-2/1 viruses
Data for 8 years of TDF treatment in chronic HBV
Different treatment strategies impact HCV disease burden
Adding a PI and infection rates in HCV-related cirrhosis
Telaprevir dosage in triple therapy for HCV GT-1
HCV RNA levels during chronic infection
Corticosteroid + antiviral therapy in chronic HBV
Please login below to download this issue (PDF)